Navigation Links
Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
Date:8/19/2008

ult of more than three years of clinical follow-up, represents a new category in skin rejuvenation: Ablative Fractional Resurfacing (AFR(TM)) treatment. The Fraxel re:pair laser delivers treatment for superficial photodamage, including pigmentation, fine lines, texture and vascular dyschromia, and has the flexibility to provide treatment for more severe rhytides and furrows by stimulating new collagen and elastin production deep into the dermis. Treatment is delivered with the safety and proven efficacy of a Fraxel brand treatment.

"We are pleased to announce that the Fraxel re:pair system is now available to physicians and their patients in Canada," said Len DeBenedictis, Chief Technology Officer of Reliant Technologies. "The latest Fraxel laser system offers consumers a one-time treatment that provides dramatic results without the side effects and downtime associated with a fully-ablative or surgical procedure."

Recently, it was announced that Reliant has agreed to join forces with Thermage, Inc. (Nasdaq: THRM) in a merger expected to close in the fourth quarter 2008.

About the Fraxel Systems

The Fraxel(R) family of products, which includes the Fraxel re:pair(TM), Fraxel re:store(TM) and the Fraxel re:fine(TM) laser systems, has quickly become the industry standard for fractional aesthetic skin treatment. Unlike traditional laser devices, Fraxel brand laser systems treat microscopic volumes of skin with each unique pulse, leaving the surrounding area intact for fast healing. Fraxel lasers have received multiple FDA clearances and have been found safe and effective in treating many areas of the face and body. The Fraxel Skin Ecology System is the only uniquely formulated cosmeceutical line designed to enhance the exp
'/>"/>

SOURCE Reliant Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
2. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
3. RainDance Technologies Appoints Olex Vice President, System Development
4. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
5. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
6. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
9. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
10. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
11. Local officials move toward monitoring nanotechnologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and NEW YORK , Dec. ... PTBIW), a biopharmaceutical company advancing patient care in critical ... of 3,500,000 shares of common stock, and warrants to ... stock, at an offering price of $4.00 per share ... share exercise price of $5.00, are exercisable immediately, and ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by ... Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End ... to 2019” provides a detailed overview of the ... and strategies impacting the preparative and process chromatography ... the revenue and share analysis. , Full ...
(Date:12/24/2014)... December 23, 2014 ... is designed to introduce cutting edge communication ... and partners of platform upgrades. This webinar ... empowering users in their quest to leverage ... , According to SoundConnect’s Marketing Manager, Seanna ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 ... mercaptan such as its definition, classification, application ... product specification, manufacturing process, and product cost ... and applications. The analysis also covers upstream ... channels, industry development trend and proposals. In ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... Data published in July 7, 2009 Issue ... Sciences, , , QUEBEC CITY, July 7 /PRNewswire-FirstCall/ - ... a global biopharmaceutical company focused on endocrine therapy and oncology, ... of the National Academy of Sciences (PNAS), of new data ...
... , THE WOODLANDS, Texas, July 7 Lexicon ... biopharmaceutical company focused on discovering and developing breakthrough treatments for ... 2 clinical trial of LX1032 , the ... carcinoid syndrome . LX1032 is designed ...
... ... and investigators at the Burnham Institute for Medical Research at Lake Nona (Burnham) announced ... microbial compounds that have potential as tools for biological research and ultimately the discovery ... ...
Cached Biology Technology:AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction 2AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction 3AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction 4Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 2Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 3Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 4Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration 2Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration 3
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... snuggle can prematurely end a love affair, as new evidence ... a smokers risk of an early heart attack. Researchers say ... population has a gene defect that delivers a one-two punch ... with this common gene variant experienced a heart attack around ...
... chance Lake Mead, a key source of water for millions ... by 2021 if climate changes as expected and future water ... at Scripps Institution of Oceanography, UC San Diego. ... River system has no buffer to sustain the population of ...
... U.S. Department of Homeland,Security (DHS) announced today ... international visitors arriving at San Francisco,International Airport ... the,department,s upgrade from two- to 10-fingerprint collection ... more accurately and,efficiently establishing and verifying visitors, ...
Cached Biology News:Cigarette after Valentine snuggle deadlier for some 2Cigarette after Valentine snuggle deadlier for some 3Lake Mead could be dry by 2021 2Lake Mead could be dry by 2021 3DHS Begins Collecting 10 Fingerprints From International Visitors at San Francisco International Airport 2
... form culture flask is designed for culturing organisms requiring ... has a heavy beaded rim to protect against chipping ... is 38mm and takes a No. 6.5 rubber stopper. ... heat source smaller than the base of the flask. ...
... to achieve in many bacterial strains due ... restriction and modification (R-M) systems that cleave ... TypeOne™ Restriction Inhibitor provides a powerful method ... with type I R-M systems. Developed ...
... cassette is designed to allow chloramphenicol ... prokaryotic promoter gb2 driving the gene ... modified version of the Em7 promoter. ... the generally used Tn5 promoter. A ...
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
Biology Products: